ES2393028B1 - PROCEDURE FOR OBTAINING A HAND CREAM. - Google Patents
PROCEDURE FOR OBTAINING A HAND CREAM. Download PDFInfo
- Publication number
- ES2393028B1 ES2393028B1 ES201130431A ES201130431A ES2393028B1 ES 2393028 B1 ES2393028 B1 ES 2393028B1 ES 201130431 A ES201130431 A ES 201130431A ES 201130431 A ES201130431 A ES 201130431A ES 2393028 B1 ES2393028 B1 ES 2393028B1
- Authority
- ES
- Spain
- Prior art keywords
- page
- paragraph
- see
- application
- glycerin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 22
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 18
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008269 hand cream Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 235000011187 glycerol Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 9
- 229960000458 allantoin Drugs 0.000 claims abstract description 9
- 239000004202 carbamide Substances 0.000 claims abstract description 9
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 8
- 239000004310 lactic acid Substances 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 239000006071 cream Substances 0.000 claims abstract description 7
- -1 ketostearyl alcohol Chemical compound 0.000 claims abstract description 7
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940086555 cyclomethicone Drugs 0.000 claims abstract description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 6
- 238000004321 preservation Methods 0.000 claims abstract description 3
- 239000000839 emulsion Substances 0.000 claims description 12
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 239000012071 phase Substances 0.000 claims description 5
- 229940096792 quaternium-15 Drugs 0.000 claims description 5
- 235000013877 carbamide Nutrition 0.000 claims description 4
- 230000003750 conditioning effect Effects 0.000 claims description 4
- 230000007794 irritation Effects 0.000 claims description 4
- 241001117804 Tetrameles Species 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 4
- 239000003921 oil Substances 0.000 claims 4
- 235000019165 vitamin E Nutrition 0.000 claims 4
- 239000011709 vitamin E Substances 0.000 claims 4
- 231100000344 non-irritating Toxicity 0.000 claims 3
- UKHVLWKBNNSRRR-TYYBGVCCSA-M quaternium-15 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C/C=C/Cl)C3 UKHVLWKBNNSRRR-TYYBGVCCSA-M 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- 235000019154 vitamin C Nutrition 0.000 claims 3
- 239000011718 vitamin C Substances 0.000 claims 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 2
- 229930003427 Vitamin E Natural products 0.000 claims 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 2
- 239000003906 humectant Substances 0.000 claims 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims 2
- 235000019155 vitamin A Nutrition 0.000 claims 2
- 239000011719 vitamin A Substances 0.000 claims 2
- 229940046009 vitamin E Drugs 0.000 claims 2
- 229940045997 vitamin a Drugs 0.000 claims 2
- 235000002961 Aloe barbadensis Nutrition 0.000 claims 1
- 244000186892 Aloe vera Species 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims 1
- 239000004264 Petrolatum Substances 0.000 claims 1
- 239000004115 Sodium Silicate Substances 0.000 claims 1
- 229930003537 Vitamin B3 Natural products 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 235000011399 aloe vera Nutrition 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000001804 emulsifying effect Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940119170 jojoba wax Drugs 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- 229960001679 octinoxate Drugs 0.000 claims 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims 1
- 229960000601 octocrylene Drugs 0.000 claims 1
- 239000011236 particulate material Substances 0.000 claims 1
- 229940066842 petrolatum Drugs 0.000 claims 1
- 235000019271 petrolatum Nutrition 0.000 claims 1
- 239000002831 pharmacologic agent Substances 0.000 claims 1
- 230000003711 photoprotective effect Effects 0.000 claims 1
- 229920002401 polyacrylamide Polymers 0.000 claims 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims 1
- 229910052911 sodium silicate Inorganic materials 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 239000011885 synergistic combination Substances 0.000 claims 1
- 235000019160 vitamin B3 Nutrition 0.000 claims 1
- 239000011708 vitamin B3 Substances 0.000 claims 1
- 239000010497 wheat germ oil Substances 0.000 claims 1
- 239000002304 perfume Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 description 4
- UKHVLWKBNNSRRR-ODZAUARKSA-M dowicil 200 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C\C=C/Cl)C3 UKHVLWKBNNSRRR-ODZAUARKSA-M 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
Abstract
Procedimiento de obtención de una crema de manos.#Según el procedimiento, la crema de manos se obtiene mediante una mezcla de componentes que corresponden aproximadamente a un 45,5% de agua, a un 10% de urea, a un 10% de glicerina, a un 15% de base 1011, a un 10% de alcohol cetoestearílico, a un 5% de ácido láctico, a un 2% de vitamina F, a un 2% de ciclometicona tetramel, a un 0,3% de alantoina y a un 0,2% de quaternium, añadiendo finalmente una dosis mínima de perfume. El producto resultante es una crema especialmente aplicable en la conservación de la piel de las manos.Procedure for obtaining a hand cream. # According to the procedure, hand cream is obtained by a mixture of components that correspond to approximately 45.5% water, 10% urea, 10% glycerin , 15% base 1011, 10% ketostearyl alcohol, 5% lactic acid, 2% vitamin F, 2% tetrame cyclomethicone, 0.3% allantoin and 0.2% quaternium, finally adding a minimum dose of perfume. The resulting product is a cream especially applicable in the preservation of the skin of the hands.
Description
Procedimiento de obtención de una crema de manos. Procedure for obtaining a hand cream.
La presente invención se refiere a un procedimiento de obtención de una crema de manos, que como preparado es un producto semisólido de aplicación cutánea y de aspecto homogéneo. The present invention relates to a method of obtaining a hand cream, which as a preparation is a semi-solid product of cutaneous application and of homogeneous appearance.
El objeto de la invención es conseguir una crema de manos, que en su aplicación no produce irritación en la piel, hidratando y acondicionando la piel de las manos. The object of the invention is to achieve a hand cream, which in its application does not cause skin irritation, moisturizing and conditioning the skin of the hands.
Son numerosas las cremas de manos que se comercializan para el tratamiento de la piel de las manos y evitar en lo posible el deterioro y envejecimiento de la piel de éstas. There are numerous hand creams that are marketed for the treatment of the skin of the hands and avoid as much as possible the deterioration and aging of the skin of these.
Sin embargo las cremas de manos que se comercializan en unos casos producen irritaciones en el usuario, dependiendo del tipo de piel que éste presente, y en otros casos la eficacia para el fin pretendido deja mucho que desear. However, hand creams that are marketed in some cases cause irritation in the user, depending on the type of skin present, and in other cases the effectiveness for the intended purpose leaves much to be desired.
Mediante el procedimiento de la invención se consigue una crema de manos que está constituida por una base compuesta en la que están disueltos los principios activos, siendo el preparado una emulsión tipo oleoacuosa, interviniendo una fase acuosa, con agua como componente mayoritario, a la que se incorpora por disolución urea, glicerina, ácido láctico y alantoina. By means of the process of the invention, a hand cream is obtained which is constituted by a compound base in which the active ingredients are dissolved, the preparation being an oleo-aqueous emulsion, intervening an aqueous phase, with water as a major component, to which it is incorporated by solution urea, glycerin, lactic acid and allantoin.
La fase oleosa corresponde a una base 1011 a la que se incorporan los principios liposolubles Abil K, vitamina F y alcohol cetoestearílico, de manera que en el momento de la elaboración se forma la emulsión, incorporando la fase oleosa a la fase acuosa, obteniéndose así una crema de manos que a efectos de tratamiento médico y previa incorporación de conservante una vez elaborada la emulsión, y ya fría, no produce irritación significativa sobre la piel , hidratando y acondicionando la piel de las manos. The oil phase corresponds to a base 1011 to which the fat-soluble principles Abil K, vitamin F and ketostearyl alcohol are incorporated, so that at the time of processing the emulsion is formed, incorporating the oil phase into the aqueous phase, thus obtaining a hand cream that for the purpose of medical treatment and prior incorporation of a preservative once the emulsion is prepared, and already cold, does not produce significant irritation on the skin, moisturizing and conditioning the skin of the hands.
Decir que en relación con el componente conservante que se incorpora a la emulsión en frío, será preferentemente el quaternium 15 (dowicil 200). To say that in relation to the preservative component that is incorporated into the cold emulsion, it will preferably be quaternium 15 (dowicil 200).
En lo que a porcentajes de componentes que participan en la elaboración o preparado de la emulsión correspondiente a la crema de manos, es como sigue: Regarding the percentages of components involved in the preparation or preparation of the emulsion corresponding to hand cream, it is as follows:
- --
- entre un 44% y un 47% de agua, between 44% and 47% of water,
- --
- entre un 8,5% y un 10% de urea, between 8.5% and 10% urea,
- --
- entre un 9,5% y un 10,5% de glicerina, between 9.5% and 10.5% glycerin,
- --
- entre un 14% y un 16% de base 1011, between 14% and 16% of base 1011,
- --
- entre un 9,5% y un 10,5% de alcohol cetoestearílico, between 9.5% and 10.5% of ketostearyl alcohol,
- --
- entre un 4,5% y un 5,5% de ácido láctico, between 4.5% and 5.5% lactic acid,
- --
- entre un 1,5% y un 2,5% de vitamina F, between 1.5% and 2.5% of vitamin F,
- --
- entre un 1,5% y un 2,5% de ciclometicona tetramel (Albil K), between 1.5% and 2.5% of tetramel cyclomethicone (Albil K),
- --
- entre un 0,2% y un 0,4% de alantoina, between 0.2% and 0.4% allantoin,
- --
- entre un 0,18% y un 0,22% de conservante, preferentemente quaternium 15, between 0.18% and 0.22% preservative, preferably quaternium 15,
- --
- añadiendo a toda la mezcla y en una pequeña dosis un perfume. adding to the whole mixture and in a small dose a perfume.
De esta manera se obtiene una crema de manos que en su aplicación resulta efectiva para la hidratación y conservación de la piel, sin producir irritación, hidratando y acondicionando la piel de las manos. In this way, a hand cream is obtained, which in its application is effective for hydration and preservation of the skin, without causing irritation, moisturizing and conditioning the skin of the hands.
2 2
Claims (2)
- Categoría Category
- 56 Documentos citados Reivindicaciones afectadas 56 Documents cited Claims Affected
- A TO
- WO 2007093830 A1 (DERMASALVE LIMITED) 23.08.2007, 1,2 WO 2007093830 A1 (DERMASALVE LIMITED) 23.08.2007, 1.2
- reivindicaciones 1,21,23. claims 1,21,23.
- A TO
- WO 0189466 A1 (THE PROCTER & GAMBLE COMPANY) 29.11.2001, 1,2 WO 0189466 A1 (THE PROCTER & GAMBLE COMPANY) 29.11.2001, 1.2
- página 4, párrafo último; página 7, párrafo segundo; página 10, párrafo último; página 19, page 4, last paragraph; page 7, second paragraph; page 10, last paragraph; page 19,
- párrafo primero; página 20, párrafos primero y tercero. first paragraph; page 20, first and third paragraphs.
- A TO
- US 20080081024 A1 (BEASLEY et al.) 03.04.2008, 1,2 US 20080081024 A1 (BEASLEY et al.) 03.04.2008, 1.2
- párrafos [0007],[0015],[0026],[0028],[0031],[0033],[0034]. paragraphs [0007], [0015], [0026], [0028], [0031], [0033], [0034].
- A TO
- WO 2006081496 A2 (NALCO COMPANY) 03.08.2006, 1,2 WO 2006081496 A2 (NALCO COMPANY) 03.08.2006, 1.2
- página 11, párrafo tercero; página 13, párrafos primero y segundo; página 14, línea 1; página 18, page 11, third paragraph; page 13, first and second paragraphs; page 14, line 1; page 18,
- línea 3; página 19 párrados quinto, penúltimo y último; reivindicación 15. line 3; page 19 fifth, penultimate and last paragraphs; claim 15.
- A TO
- US 7368122 B1 (DOW et al.) 06.05.2008, 1,2 US 7368122 B1 (DOW et al.) 06.05.2008, 1.2
- columna 6, líneas 3,14-15; ejemplo 1. column 6, lines 3.14-15; Example 1.
- Categoría de los documentos citados X: de particular relevancia Y: de particular relevancia combinado con otro/s de la misma categoría A: refleja el estado de la técnica O: referido a divulgación no escrita P: publicado entre la fecha de prioridad y la de presentación de la solicitud E: documento anterior, pero publicado después de la fecha de presentación de la solicitud Category of the documents cited X: of particular relevance Y: of particular relevance combined with other / s of the same category A: reflects the state of the art O: refers to unwritten disclosure P: published between the priority date and the date of priority submission of the application E: previous document, but published after the date of submission of the application
- El presente informe ha sido realizado • para todas las reivindicaciones • para las reivindicaciones nº: This report has been prepared • for all claims • for claims no:
- Fecha de realización del informe 29.11.2012 Date of realization of the report 29.11.2012
- Examinador S. González Peñalba Página 1/4 Examiner S. González Peñalba Page 1/4
- Novedad (Art. 6.1 LP 11/1986) Novelty (Art. 6.1 LP 11/1986)
- Reivindicaciones Reivindicaciones 1, 2 SI NO Claims Claims 1, 2 IF NOT
- Actividad inventiva (Art. 8.1 LP11/1986) Inventive activity (Art. 8.1 LP11 / 1986)
- Reivindicaciones Reivindicaciones 1, 2 SI NO Claims Claims 1, 2 IF NOT
- Documento Document
- Número Publicación o Identificación Fecha Publicación Publication or Identification Number publication date
- D01 D01
- WO 2007093830 A1 (DERMASALVE LIMITED) 23.08.2007 WO 2007093830 A1 (DERMASALVE LIMITED) 08/23/2007
- D02 D02
- WO 0189466 A1 (THE PROCTER & GAMBLE COMPANY) 29.11.2001 WO 0189466 A1 (THE PROCTER & GAMBLE COMPANY) 29.11.2001
- D03 D03
- US 20080081024 A1 (BEASLEY et al.) 03.04.2008 US 20080081024 A1 (BEASLEY et al.) 04.04.2008
- D04 D04
- WO 2006081496 A2 ( NALCO COMPANY) 03.08.2006 WO 2006081496 A2 (NALCO COMPANY) 03.08.2006
- D05 D05
- US 7368122 B1 (DOW et al.) 06.05.2008 US 7368122 B1 (DOW et al.) 06.05.2008
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201130431A ES2393028B1 (en) | 2011-03-24 | 2011-03-24 | PROCEDURE FOR OBTAINING A HAND CREAM. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201130431A ES2393028B1 (en) | 2011-03-24 | 2011-03-24 | PROCEDURE FOR OBTAINING A HAND CREAM. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2393028A1 ES2393028A1 (en) | 2012-12-17 |
| ES2393028B1 true ES2393028B1 (en) | 2013-11-05 |
Family
ID=47227275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201130431A Expired - Fee Related ES2393028B1 (en) | 2011-03-24 | 2011-03-24 | PROCEDURE FOR OBTAINING A HAND CREAM. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2393028B1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003534260A (en) * | 2000-05-23 | 2003-11-18 | ザ、プロクター、エンド、ギャンブル、カンパニー | Moisturizing and sunscreen compositions for skin care containing organic particulate matter |
| US7368122B1 (en) * | 2002-03-08 | 2008-05-06 | Dow Pharmaceutical Sciences | Skin cream |
| WO2006081496A2 (en) * | 2005-01-27 | 2006-08-03 | Nalco Company | Personal care composition containing hydrophobically modified polymers |
| GB0603167D0 (en) * | 2006-02-17 | 2006-03-29 | Dermasalve Sciences Ltd | Skin application |
| US20080081024A1 (en) * | 2006-10-02 | 2008-04-03 | Beasley Donathan G | Photoprotective compositions comprising synergistic combination of sunscreen active compounds |
-
2011
- 2011-03-24 ES ES201130431A patent/ES2393028B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2393028A1 (en) | 2012-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11571373B2 (en) | Skin care preparations for babies | |
| ES2285158T3 (en) | TOPIC PHARMACEUTICAL COMPOSITIONS THAT INCLUDE PROANTOCIANIDINS, GLYRRETINIC ACID AND TELMESTENIA FOR THE TREATMENT OF DERMATITIS. | |
| ES2269781T3 (en) | SYNERGIC MIXTURES OF 1,2-ALCANODIOLS. | |
| ES2301637T3 (en) | DERMATOLOGICAL AND COSMETIC COMPOSITIONS THAT INCLUDE A FURFURILE DERIVATIVE. | |
| CN109152716B (en) | Taurine and aloe vera synergistic anti-irritant compositions and methods | |
| ES2310549T3 (en) | DERMIC COMPOSITIONS CONTAINING COENZYME Q AS ACTIVE PRINCIPLE. | |
| PL214285B1 (en) | Use of purslane to treat facial wrinkles | |
| KR960000855A (en) | L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same | |
| ES2358925T3 (en) | ANTI-INFLAMMATORY COMPOSITIONS AND USE PROCEDURES. | |
| DE202005007603U1 (en) | Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil | |
| ES2393028B1 (en) | PROCEDURE FOR OBTAINING A HAND CREAM. | |
| KR20080003910A (en) | Skin cosmetics and wrinkle improvers | |
| KR102670049B1 (en) | Cosmetic composition for exfoliating and pad having the same | |
| ES2380862B2 (en) | CREAM OF SHAVING FOR THE TREATMENT OF ACNE AND IRRITATIONS AND INFECTIONS CAUSED BY ACNE. | |
| JP4934280B2 (en) | Wrinkle improving agent | |
| Mali et al. | A conceptual study on cosmetic toxicity wsr to Dushi Visha | |
| WO2018015593A1 (en) | Compositions comprising cromoglicic acid for the treatment of dermatitis | |
| JP6671832B2 (en) | Heat shock protein expression inducer | |
| ES2830379T3 (en) | Combination of at least one protease inhibitor and dexpanthenol for use in the prevention and / or treatment of skin lesions | |
| ES2382845B2 (en) | IMPROVEMENTS INTRODUCED IN THE MAIN PATENT P200400524 FOR "NATURAL LIQUID COMPOSITION AGAINST INFECTIONS". | |
| KR101548254B1 (en) | Composition for treating skin disease comprising sulfur, alum and vinegar | |
| Albert | Nineteenth-century patent medicines for the skin and hair | |
| RU2563811C1 (en) | Pharmaceutical composition for treating mycotic diseases | |
| ES2180439B2 (en) | COSMETIC-DERMATOLOGICAL COMPOSITION. | |
| ES2517790A1 (en) | Composition for the treatment of dandruff (Machine-translation by Google Translate, not legally binding) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2393028 Country of ref document: ES Kind code of ref document: B1 Effective date: 20131105 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20181015 |